A comprehensive view of AmerisourceBergen Corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AmerisourceBergen releases 2022 ESG Summary Report; highlights include goal to cut Scope 1 & 2 greenhouse gas emissions 54.6% by FY2032 from a FY2019 base year, UK’s Alliance Healthcare cuts single-use plastic secondary packaging by 60% over three years
Published: February 08, 2023 by AmerisourceBergen Corp.
AmerisourceBergen serving as generic pharmaceutical firm Civica’s exclusive distribution and supply chain partner for Civica members; partnership being rolled out in phases in first half of 2023 and aims to ensure supply of generic medicines nationwide
Published: January 27, 2023 by Business Wire
AmerisourceBergen to change name to Cencora; as Cencora, the company will continue to invest in and focus on its core pharmaceutical distribution business and grow its pharma and biopharma services platform to support pharmaceutical innovation and access
Published: January 24, 2023 by AmerisourceBergen Corp.
AmerisourceBergen completes acquisition of PharmaLex, a specialized services provider to the pharmaceutical, biotech medical device industries; deal will build AmerisourceBergen’s European pharmaceutical distribution, biopharma manufacturer services
Published: January 06, 2023 by Marketline - Deals
Fitch: Affirming AmerisourceBergen at A-/F2 on stable outlook, with US$1.5B-US$2B in free cash flow, US$5.7B of outstanding debt; Alliance and PharmaLex acquisitions expected to strengthen company's higher margin services to pharmaceutical manufacturers
Published: December 29, 2022 by ENP Newswire

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count